Cervical cancer patients who had distant metastasis had 12.82 times chance of having ADAM9-positive expression as compared with cervical cancer patients without distant metastasis (95% CI 1.91, 86.13; p = 0.009). Here, ADAM9 is linked to cervical cancer.